-
-
-
-
-
-
-
Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Ensysce Biosciences Receives Notice of Award for Year Three of Multi-Year NIDA Grant for the Clinical Development of its Next Generation Opioid Products with Overdose Protection
-
-
-
-
-
1,162,832 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

